Clinical Trials
clinical trials
Phase I/II clinical trials of GL-ONC1 are expected to begin within the next year in multiple highly-regarded clinical research institutions in the U.S. and in Europe. Once patient selection begins, information about participating in the trial will be available from clinical partners and on the Internet at www.clinicaltrials.gov.